Validity of Viome's Oral/throat Cancer Test

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 27, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Oral and Throat CancerOropharyngeal Squamous Cell CarcinomaOral Squamous Cell Carcinoma
Interventions
DEVICE

Oral/Throat cancer test

The Oral/Throat cancer test is intended for the qualitative detection of molecular features (human genes, microbial species and functions) associated with Oral Squamous Cell Carcinoma (OSCC) or OroPharyngeal Squamous Cell Carcinoma (OPSCC) in saliva samples from adults with a suspicion of cancer. A positive result from CDOT may indicate the presence of OSCC or OPSCC. The device is intended as a diagnostic aid for clinicians when assessing patients with suspected OSCC or OPSCC who may benefit from follow-up diagnosis and treatment. The device is not intended for a definitive diagnosis.

Trial Locations (2)

38163

RECRUITING

UTHSC, Memphis

63104

RECRUITING

Missouri School of Dentistry & Oral Health, St Louis

All Listed Sponsors
lead

Viome

INDUSTRY